(AP)-Pfizer is set to ask U.S. regulators to allow emergency use of its COVID-19 vaccine, starting a process that could bring first shots as early as next month.
Friday’s step comes days after Pfizer and its German partner BioNTech announced its vaccine appears 95% protective in a large but not yet finished study.
Over the next few weeks, the Food and Drug Administration and its scientific advisers will have to decide if there’s really enough evidence to allow emergency vaccinations.
If so, first supplies will be scarce and rationed. Experts warn it likely will be spring before there’s enough for everyone.
- Here’s why it’s crucial to quarantine for 14 days after COVID-19 exposure
- Biden begins nominating cabinet members as Trump continues to fight election results
- Digital First: How to Fry Your Turkey for Thanksgiving
- UMMC doctors warn about coronavirus spread during holidays
- Website offering “dream job” paying $2,500 to watch 25 holiday movies in 25 days